Hemato-oncology

1144x620
Investment and continued research into solutions for blood diseases

Hemato-oncology

Medicines

CAR-T

Kite, a Gilead company, specializes in creating innovative cancer drugs. They focus on CAR-T (Chimeric Antigen Receptor) cell treatments, available in Belgium for the treatment of patients with specific types of lymphomas.

To update stakeholders on CAR-T advancements, Kite has launched the Cell Therapy Hub, a portal dedicated to healthcare professionals.

Find out more
CART-Cell-Therapy_1
Infographics

The CAR-T cell pathway

Access here
CART Cell Therapy
Infographics

The History of Cellular Therapy

Access here

Meet our team

Ruth-VanDaele-without-phone

Ruth Van Daele

Manager, Medical Affairs
Contact
GILEAD_KITE_Logo_Stack_RGB_012622
Request for Medical Information
Contact
Card-List-Anne-Marie-Without-Phone

Anne Marie Omogrosso

Senior Cell Therapies Account Manager
Contact
Card-List-Mario-De-Moor-Without-Phone

Mario De Moor

Senior Cell Therapies Account Manager
Contact

BE-YES-0081